Flourish™ Pediatric Esophageal Atresia
| Status: | Recruiting |
|---|---|
| Conditions: | Gastrointestinal |
| Therapuetic Areas: | Gastroenterology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 3/16/2019 |
| Start Date: | November 5, 2018 |
| End Date: | November 2022 |
| Contact: | Julie Whitaker |
| Email: | Julie.Whitaker@cookmedical.com |
| Phone: | 800.356.9208 |
Flourish Pediatric Esophageal Atresia Device Post-Approval Study (Flourish)
This study is continued evaluation of the safety and probable benefit of the Flourish
Pediatric Esophageal Atresia device through the Humanitarian Device Exemption (HDE) pathway.
Pediatric Esophageal Atresia device through the Humanitarian Device Exemption (HDE) pathway.
Inclusion Criteria:
- Has esophageal atresia (EA)
Exclusion Criteria:
- Greater than 1 year of age
- Presence of visible teeth
- Parent or guardian of patient unwilling or unable to provide informed consent for use
of data
We found this trial at
7
sites
Boston Children's Hospital Boston Children's Hospital is a 395-bed comprehensive center for pediatric health care....
Click here to add this to my saved trials
Children's Hospital of Philadelphia Since its start in 1855 as the nation's first hospital devoted...
Click here to add this to my saved trials
University of Chicago Medical Center The University of Chicago Medicine has been at the forefront...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials